CIFoundry
Back to Catalog
Oncology
FDA De Novo

Clairity Breast

Save to shortlist
Clairity

Last reviewed Oct 31, 2026 against the sources listed on this page · How we review

At a glance

Clairity Breast is an AI tool that predicts a woman's five-year breast cancer risk from a standard screening mammogram.

FDA:
De Novo DEN240047
Epic:
Not on record
Named users:
1 named in public reports
Published study:
Not on record

Description

Clairity Breast is an AI tool that predicts a woman's five-year breast cancer risk from a standard screening mammogram. It was the first image-based breast cancer risk prediction tool granted FDA De Novo authorization (June 2025).

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Is Clairity Breast FDA cleared?
The public FDA database has one record that our team matched to Clairity Breast. The most recent is De Novo DEN240047 (Allix5), decided May 2025. Check that the cleared use matches how you plan to use it.FDA record DEN240047
Which health systems use Clairity Breast?
Linked public reports name one organization: BIDMC. "Who's using this" below lists them all, plus any the maker reports. Ask the vendor for a reference at an organization like yours.BIDMC (AuntMinnie)

Security & contracting

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Not assessed

Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

1 organization

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

Last checked Oct 31, 2026. Spot an error? Let us know through the discussion below.

Get weekly updates for Oncology

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website

FDA database records

Matched by our team from the public FDA database; checked Nov 10, 2026.

History (3)Show

Dated events on this listing's public record, newest first.

  1. Oct 31, 2026

    Added to CIFoundry

  2. Feb 24, 2026

    News report names BIDMC as a user (AuntMinnie)source

  3. May 30, 2025

    FDA De Novo DEN240047 decision datesource

Developer

Clairity

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.